Abstract:OBJECTIVE:To investigate the expression of fascin and cytokeratin 14 (CK14) in human esophageal squamous cell carcinoma (ESCC) and the association of these two proteins with ESCC malignant progression and the possibility of application of these 2 proteins in the diagnosis of ESCC.METHODS:A tissue microarray composed of the representative regions of ESCC and corresponding normal epithelium was constructed. Immunohistochemistry was conducted to examine the expression of fascin and CD14 in 116 specimens of ESCC and the normal tissues near the cancerous tissues. The relation of these two proteins with the invasive depth, node involvement, differentiated grade, pTNM stages was analyzed. Disease-free survival analysis was carried out using Kaplan-Meier method. The correlation of the two proteins was analyzed using Spearman's correlation test. ESCC cells of the lines EC9706, TE12, COLO-680N, KYSE510, KYSE450, KYSE410, KYSE180, KYSE150, KYSE140, KYSE70, KYSE30, and YES2 were cultured and underwent SDS-PAGE and Western blotting to examine the expression of fascin and CD14. And the correlation of the two proteins with the characteristics of the cell lines was analyzed too.RESULTS:Fascin and CK14 were negative in the normal esophageal epithelia except in the basal cells. The positive rates of fascin and CK14 in the ESCC cells were 79.3% and 67.0% respectively. The positive rate of either fascin or CK14 was 86.2%. The expression rates of fascin and CK14 in well- and moderately-differentiated ESCCs were significantly higher than that in the poorly-differentiated ones (P = 0.054 and P < 0.01). The patients with positive expression of fascin and those with negative expression of CK14 had a poorer survival in comparison with those with negative fascin expression and those with positive CK14 expression respectively, however, without statistical significances (P = 0.8980 and P = 0.2610). The positive rates of fascin in the well-, moderately-, and poorly- differentiated ESCCs were 87.1%, 83.9%, and 62.1% respectively (P = 0.054). The positive rates of CK14 in the well-, moderately-, and poorly-differentiated ESCCs were; 87.1%, 76.4%, and 27.6% respectively (P < 0.01). The prognosis was not significantly correlated with the expression of both proteins (P = 0.8980 and P = 0.2610). There was an significantly positive correlation between the expression levels of these 2 proteins (r = 0.487, P < 0.01). Fascin was highly expressed in most of the ESCC lines, except in the slowly growing and weakly migrating TE12 line. High expression of CK14 was only seen in the line KYSE180.CONCLUSION:Fascin and CK14 may play important roles in the carcinogenesis and progression of ESCC. Combination of fascin and CK14 would be valuable markers in diagnosis of ESCC.

Expression and Clinical Significance of Cyclin G1 and Cyclin G2 in Human Esophageal Squamous Cell Carcinoma

Expressions and Significance of Cyclin B1 and D1 in Human Esophageal Squamous Cell Carcinoma

[Expression of Fascin and Cytokeratin 14 in Esophageal Squamous Cell Carcinoma].

Cyclin D1 Expression in Esophageal Cancer and Its Clinical Significance

Clinicopathological Significance of Cyclooxygenase-2 and Cell Cycle-Regulatory Proteins Expression in Patients with Esophageal Squamous Cell Carcinoma.

The Expression and Clinical Significance of HIF-1α, Survivin,CyclinD 1 in Esophageal Squamous Cancer

Expression of Cyclin D1 Protein in Stage T2-3N0M0 Esophageal Carcinoma and Its Relationship with Prognosis

The clinical significance of p53 and pRb signal pathway in esophageal cancer patients

Expression of CDC2,CLDN5 and its clinical significance in esophageal squamous cell carcinoma

Expressions of MCM2 and CDC2 in esophageal squamous cell carcinoma and their clinical significance

The Expression of Cyclin E in Oral Precancerous Lesions and Squamous Cell Carcinomas and Its Significance

Overexpression of cyclin-dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance

EXPRESSION AND CLINICAL SIGNIFICANCE OF CYCLIN G1 AND CYCLIN G_2 IN TRANSITIONAL CELL CARCINOMA OF BLADDER

Expression of P53, P16 and Cyclooxygenase-2 in Esophageal Cancer with Tissue Microarray

[Flow Cytometric Detection and Significance of Four Cyclins in Esophageal Cancer].

Cyclin D1 overexpression in esophageal cancer from southern China and its clinical significance.

Expression of EGFR,GST-π and C-erbB-2 in esophageal squamous cell carcinoma and their clinical significance

Relationship between COX-2 and cell cycle-regulatory proteins in patients with esophageal squamous cell carcinoma.

Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma

Expression of PC Cell-Derived Growth Factor and Vascular Endothelial Growth Factor in Esophageal Squamous Cell Carcinoma and Their Clinicopathologic Significance.

Expression and significance of tumor drug resistance related proteins and β-catenin in esophageal squamous cell carcinoma